Earlier this month, Genentech offered countless academics and other researchers up to $125,000 in grants to generate papers ...
Genentech recently announced a series of marketing leadership hires to start off the new year. The biotech company hired Erica Taylor, PhD, as the company’s first chief marketing officer and tabbed ...
Late-breaking Phase II data highlight enicepatide’s (CT-388) efficacy and safety, reinforcing its potential to deliver best-in-class weight loss across a broad population of people living with ...
Biotechnology company Genentech is expanding its local manufacturing capabilities with a $450 million investment in its Oceanside campus. Genentech was founded in 1976 and has been considered a ...
WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for ...
A rendering of the new biotech facility in Oceanside. Courtesy of Genentech Genentech has begun a $450 million expansion of its biotech campus in Oceanside with a new facility that will produce ...
Add Yahoo as a preferred source to see more of our stories on Google. https://www.tipranks.com/news/the-fly/precigen-sees-q1-revenue-exceeding-18m-consensus-20-8m ...
InvestorsHub on MSN
Genentech highlights new breast cancer and precision oncology data ahead of ASCO 2026 (RHHBY)
Roche’s Genentech unit is emphasizing next-generation breast cancer therapies, targeted oncology combinations and brain-penetrating treatments at ASCO 2026. Key Investor Takeaways ・Genentech, part of ...
In time for Mother’s Day, Genentech released a new Vabysmo ad suggesting that a great way to repay your mother for her years of love and support is with a prescription for the wet age-related macular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results